ArticleTransboundary and emerging diseases2026
Genetic Diversity, Recombination, and Pathogenicity of Porcine Epidemic Diarrhea Virus Strains Circulating in China During 2023-2024.
Article in Transboundary and emerging diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Isolation and assessment of characterization of porcine epidemic diarrhea virus GD1 strain from China.Frontiers in veterinary science · 2026Article
- Genetic Diversity, Recombination, and Pathogenicity of Porcine Epidemic Diarrhea Virus Strains Circulating in China During 2023-2024.Transboundary and emerging diseases · 2026Article
Corrections and comments
- Erratum issued
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Porcine epidemic diarrhea virus (PEDV) is an enteric alphacoronavirus that causes severe diarrhea and high mortality in neonatal piglets, posing a persistent threat to the global swine industry. Despite extensive vaccination, PEDV continues to circulate in China, underscoring the need for updated molecular epidemiological surveillance. Here, we investigated the prevalence, genetic diversity, and pathogenicity of PEDV strains circulating in China during 2023-2024. A total of 714 clinical samples were collected from diarrheic pigs in seven major swine-producing regions. PEDV RNA was detected in 36.27% of samples, with substantial positivity observed in both anal and nasal swabs. Phylogenetic analysis based on the full-length S gene revealed that circulating strains clustered into multiple subgroups, including GIa, GIIa, GIIb, and GIIc, with GIIc being predominant, indicating pronounced genetic diversity and co-circulation of distinct lineages. Two PEDV strains were isolated from PEDV-positive intestinal tissues and designated PEDV-HeiHo-2024 (GIIb) and PEDV-NJZU-2024 (GIa). Recombination analysis identified PEDV-HeiHo-2024 as a putative recombinant derived from distinct GII lineage strains. Comparative analyses of key neutralizing epitopes and N-linked glycosylation sites in the S protein revealed substantial divergence from classical vaccine strains. Experimental infection of neonatal piglets demonstrated that PEDV-HeiHo-2024 induced severe diarrhea and characteristic intestinal lesions, confirming its high pathogenicity, whereas PEDV-NJZU-2024 showed no apparent pathogenic effects. Collectively, these findings highlight the continued circulation of genetically diverse and pathogenic PEDV strains in China and emphasize the importance of sustained molecular surveillance and vaccine updates.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.